Orally-induced intestinal CD4+ CD25+ FoxP3+ treg controlled undesired responses towards oral antigens and effectively dampened food allergic reactions

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Smaldini, Paola Lorena ^a   Delgado, María Lucía Orsini ^a   Fossati, Carlos Alberto ^a   Docena, Guillermo Horacio ^a  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; MILK PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CHOLERA TOXIN; IL10 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; DRUG RESPONSE; FOOD ALLERGY; GENE; GENE EXPRESSION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTERLEUKIN 13 GENE; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; MALE; MILK; MILK ALLERGY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ORAL IMMUNOTHERAPY; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH2 CELL; ANIMAL; DISEASE MODEL; FOOD HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; PROCEDURES;

ANIMALS; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; FOOD HYPERSENSITIVITY; IMMUNOTHERAPY; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-5; MALE; MICE; MILK PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84951196714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141116     Document Type: Article

References (42)

1. Sicherer SH, Sampson H a. Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment. The Journal of allergy and clinical immunology. 2014; 133(2):291-307. doi: 10.1016/j.jaci.2013.11.020 PMID: 24388012
2. Isolauri E, Sütas Y, Salo MK, Isosomppi R, Kaila M. Elimination diet in cow's milk allergy: Risk for impaired growth in young children. The Journal of pediatrics. 1998; 132(6):1004-9. PMID: 9627594
3. Berin MC, Sampson HA. Food allergy: an enigmatic epidemic. Trends in Immunology. 2013; 34 (8):390-7. doi: 10.1016/j.it.2013.04.003 PMID: 23648309
4. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. The Journal of Experimental Medicine. 2004; 199(12):1679-88. PMID: 15197226
5. Wang J, Sampson HA. Food allergy. The Journal of Clinical Investigation. 2011; 121(3):827-35. doi: 10.1172/JCI45434 PMID: 21364287
6. Sicherer SH. Epidemiology of food allergy. Journal of Allergy and Clinical Immunology. 2011; 127 (3):594-602. doi: 10.1016/j.jaci.2010.11.044 PMID: 21236480
7. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. The Journal of Allergy and Clinical Immunology. 2009; 123(4):735-46. doi: 10.1016/j.jaci.2009. 02.030 PMID: 19348912
8. Moran TP, Vickery BP, Burks a W. Oral and sublingual immunotherapy for food allergy: current progress and future directions. Current opinion in immunology. 2013; 25:1-7.
9. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy. 2007; 62 (11):1261-9. PMID: 17919140
10. Pajno GB, Caminiti L, Ruggeri P, De Luca R, Vita D, La Rosa M, et al. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Annals of Allergy, Asthma & Immunology. 2010; 105(5):376-81.
11. Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. The Journal of allergy and clinical immunology.2008; 122(6):1154-60. doi: 10.1016/j.jaci.2008.09.030 PMID: 18951617
12. Rolinck-Werninghaus C, Staden U, Mehl a, Hamelmann E, Beyer K, Niggemann B. Specific oral tolerance induction with food in children: transient or persistent effect on food allergy? Allergy. 2005; 60 (10):1320-2. PMID: 16135001
13. Vickery B, Scurlock A, Jones S, Buerks W. Mechanisms of Immune Tolerance Relevant to Food Allergy. The Journal of allergy and clinical immunology. 2012; 127(3):576-86.
14. Xu L, Kitani A, Strober W. Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal Immunology. 2010; 3(3):230-8. doi: 10.1038/mi.2010.7 PMID: 20404810
15. Smaldini P, Curciarello R, Candreva A, Rey MA, Fossati CA, Petruccelli S, et al. In vivo evidence of cross-reactivity between cow's milk and soybean proteins in a mouse model of food allergy. International archives of allergy and immunology. 2012; 158(4):335-46. doi: 10.1159/000333562 PMID: 22472742
16. Smaldini PL, Ibañez AE, Fossati CA, Cassataro J, Docena GH. Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy. Human vaccines & immunotherapeutics. 2014; 10(7):1-9.
17. Ibañez AE, Smaldini P, Coria LM, Delpino MV, Pacífico LGG, Oliveira SC, et al. Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins. PloS one. 2013; 8(7): e69438. doi: 10.1371/journal.pone.0069438 PMID: 23861971
18. Curciarello R, Smaldini PL, Candreva AM, González V, Parisi G, Cauerhff A, et al. Targeting a crossreactive Gly m 5 soy peptide as responsible for hypersensitivity reactions in a milk allergy mouse model. PloS one. 2014; 9(1):e82341. doi: 10.1371/journal.pone.0082341 PMID: 24416141
19. Smaldini PL, Stanford J, Romanin DE, Fossati CA, Docena GH. Down-regulation of NF-êB signaling by Gordonia bronchialis prevents the activation of gut epithelial cells. Innate immunity. 2013
20. Docena G, Rovedatti L, Kruidenier L, Fanning A, Leakey NAB, Knowles CH, et al. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogenactivated protein kinase inhibitors in inflammatory bowel disease. Clinical and Experimental Immunology. 2010; 162(1):108-15. doi: 10.1111/j.1365-2249.2010.04203.x PMID: 20731675
21. Broek J, Terracciano L, Hsu J, Kreis J, Compalati E, Santesso N, et al. Oral immunotherapy for IgEmediated cow's milk allergy: a systematic review and meta-analysis. Clinical Experimental Allergy. 2012; 3(42):363-74.
22. Burks AW, Jones SM, Wood RA, Fleischer DM, Vickery BP, Liu AH, et al. Oral Immunotherapy for Treatment of Egg Allergy in Children. N Engl J Med. 2012; 367(3):233-43. doi: 10.1056/ NEJMoa1200435 PMID: 22808958
23. Sánchez-García S, Rodríguez del Río P, Escudero C, García-Fernández C, Ramirez A, Ibáñez MD. Efficacy of oral immunotherapy protocol for specific oral tolerance induction in children with cow's milk allergy. The Israel Medical Association journal: IMAJ. 2012; 14(1):43-7. PMID: 22624442
24. Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, et al. A randomized control study of peanut oral immunotherapy (OIT): clinical desensitization and modulation of the allergic response. The Journal of allergy and clinical immunology. 2012; 127(3):654-60.
25. Enrique E, Pineda F, Malek T, Bartra J, Basagaña M, Tella R, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. The Journal of Allergy and Clinical Immunology. 2005; 116(5):1073-9. PMID: 16275379
26. Høst A, Halken S. A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy. 1990; 45(8):587-96. PMID: 2288394
27. Fiocchi A, Brozek J, Schünemann H, Bahna SL, von Berg A, Beyer K, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2010; 21 Suppl 2:1-125.
28. Krogulska A, Borowiec M, Polakowska E, Dynowski J, M?ynarski W, Wasowska-Królikowska K. FOXP3, IL-10, and TGF-β genes expression in children with IgE-dependent food allergy. Journal of clinical immunology. 2011; 31(2):205-15. doi: 10.1007/s10875-010-9487-1 PMID: 21107665
29. Gonnella P, Waldner HP, Weiner HL. B Cell-Deficient (MT) Mice Have Alterations in the Cytokine Microenvironment of the Gut-Associated Lymphoid Tissue (GALT) and a Defect in the Low Dose Mechanism of Oral Tolerance. The Journal of Immunology. 2001; 166(7):4456-64. PMID: 11254701
30. Ashour HM, Niederkorn JY. Expansion of B cells is necessary for the induction of T-cell tolerance elicited through the anterior chamber of the eye. International archives of allergy and immunology. 2007; 144(4):343-6. PMID: 17671393
31. Ashour HM, Seif TM. The role of B cells in the induction of peripheral T cell tolerance. Journal of leukocyte biology. 2007; 82(5):1033-9. PMID: 17656652
32. Adel-Patient K, Wavrin S, Bernard H, Meziti N, Ah-Leung S, Wal J-M. Oral tolerance and Treg cells are induced in BALB/c mice after gavage with bovine β-lactoglobulin. Allergy. 2011; 66(10):1312-21. doi: 10.1111/j.1398-9995.2011.02653.x PMID: 21615416
33. Yamada T, Tongu M, Goda K, Aoi N, Morikura I, Fuchiwaki T, et al. Sublingual Immunotherapy Induces Regulatory Function of IL-10-Expressing CD4(+)CD25(+)Foxp3(+) T Cells of Cervical Lymph Nodes in Murine Allergic Rhinitis Model. Journal of allergy. 2012:490905. doi: 10.1155/2012/490905 PMID: 23118775
34. Rupa P, Mine Y. Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy. Allergy. 2012; 67(1):74-82. doi: 10.1111/j.1398-9995.2011.02724.x PMID: 21950267
35. Hossain DMS, Panda AK, Manna A, Mohanty S, Bhattacharjee P, Bhattacharyya S, et al. FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity. 2013; 39 (6):1057-69. doi: 10.1016/j.immuni.2013.11.005 PMID: 24315995
36. Bottema RWB, Kerkhof M, Reijmerink NE, Koppelman GH, Thijs C, Stelma FF, et al. X-chromosome Forkhead Box P3 polymorphisms associate with atopy in girls in three Dutch birth cohorts. Allergy. 2010; 65(7):865-74. doi: 10.1111/j.1398-9995.2009.02291.x PMID: 20028375
37. Nguyen KD, Vanichsarn C, Fohner A, Nadeau KC. Selectiv deregulation in chemokine signaling pathways of CD4+CD25hiCD127lo/- regulatory T cells in human allergic asthma. Journal of Allergy and Clinical Immunology. 2009; 123(4):933-9. doi: 10.1016/j.jaci.2008.11.037 PMID: 19152963
38. Kobayashi I, Kubota M, Yamada M, Tanaka H, Itoh S, Sasahara Y, et al. Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3. Clinical immunology (Orlando, Fla.).2011; 141(1):83-9.
39. Syed A, Garcia M a, Lyu S-C, Bucayu R, Kohli A, Ishida S, et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). The Journal of allergy and clinical immunology. 2014; 133(2):500-10. doi: 10.1016/j.jaci. 2013.12.1037 PMID: 24636474
40. Fischer J, Hueber AJ, Wilson S, Galm M, Baum W, Kitson C, et al. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody. Arthritis & rheumatology (Hoboken, N.J.). 2015; 67 (1):51-62.
41. Li Q, Ren G, Xu L, Wang Q, Qi J, Wang W, et al. Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model. International immunopharmacology. 2014; 21(1):119-27. doi: 10.1016/j.intimp.2014.04.018 PMID: 24800661
42. Bhattacharya P, Fan J, Haddad C, Essani A, Gopisetty A, Eishabrawy H, et al. A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of Type 1 diabetes in NOD mice. Clinical Immunology. 2015; 153(1):187-98.